Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-107220
Filing Date
2018-04-04
Accepted
2018-04-04 12:43:38
Documents
9
Period of Report
2018-05-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A d548699dpre14a.htm PRE 14A 426038
2 GRAPHIC g548699g13u48.jpg GRAPHIC 3285
3 GRAPHIC g548699g41i08.jpg GRAPHIC 3319
4 GRAPHIC g548699g49s96.jpg GRAPHIC 1965
5 GRAPHIC g548699g62d33.jpg GRAPHIC 29678
6 GRAPHIC g548699g68w92.jpg GRAPHIC 55887
7 GRAPHIC g548699g77w35.jpg GRAPHIC 1697
8 GRAPHIC g548699g91g89.jpg GRAPHIC 3451
9 GRAPHIC g548699g99q48.jpg GRAPHIC 1961
  Complete submission text file 0001193125-18-107220.txt   567688
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 033-80623 | Film No.: 18736490
SIC: 2835 In Vitro & In Vivo Diagnostic Substances